
BlueWind Medical Announces Two-Year Durability Data for Revi® System
BlueWind Medical Announces Two-Year Durability Data for Revi® System BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) therapies, announced today the publication of the two-year results from its pivotal OASIS study in the Journal of Urology (March 2025…












